Glucagon Emergency Kit for Low Blood Sugar

Lupin Pharmaceuticals Inc. has recalled Glucagon Emergency Kit for Low Blood Sugar, according to data published by the U.S. Food and Drug Administration (FDA). The recall was reported on July 8, 2026 and was initiated on June 23, 2026. It is classified as a Not Yet Classified recall, which means the agency has not assigned a standard severity class to this recall.

Below is a plain-English summary of what was recalled, why it was recalled, how to tell whether you have the affected product, and what steps you can take. For the complete and most current details, you can view the FDA record linked further down this page.

What was recalled?

This recall covers Glucagon Emergency Kit for Low Blood Sugar, with approximately 64,894 units affected. The company behind the recall is Lupin Pharmaceuticals Inc., based in Naples, FL. The FDA describes the product as: “Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection USP, 1mg per vial, Diluent for Glucagon, 1 mL syringe, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured by: Lupin Limited, Nagpur - 441108, INDIA, NDC 707…”

Why was Glucagon Emergency Kit for Low Blood Sugar recalled?

According to the FDA, the stated reason for the recall is: “CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing.” In plain terms, this recall relates to a manufacturing quality issue (CGMP).

CGMP stands for Current Good Manufacturing Practice — the FDA's quality rules for how medicines must be made, tested, and documented. A CGMP-related recall means the manufacturing process did not meet those standards. It does not automatically mean the medicine is harmful, but the FDA cannot be confident in its quality, so it is removed from the market.

What should you do?

If you think you may have bought Glucagon Emergency Kit for Low Blood Sugar, compare it against the product description and identifying codes (Kit Lots: WB00010, Exp. Date Jan 2027; WB00017, WB00019, Exp. Date Feb 2027; WB00070, Exp. Date Jun 2027; WB00077, WB00078, Exp. Date Jul 2027; WB00130, Exp. D…) before using it. This recall is currently listed as ongoing.

The general guidance for a matching product is to stop using it and follow the instructions in the official FDA recall notice, which may include a repair, replacement, refund, or safe disposal. When in doubt, contact Lupin Pharmaceuticals Inc. or your local health authority.

About this recall

This recall was distributed in FL. RecallRadar summarizes recall information from public FDA data to make it easier to understand. We are an independent service and are not affiliated with the FDA or any government agency, so please always refer to the official source for the authoritative record — and note the “last synced” date shown on this page, since recall details can change over time.